Concepedia

Nathaniel H. Greenberg

NH

Statistics

Publications

6

Citations

1.2K

H-Index

6

Active since

1963

Affiliations

National Cancer Institute(Current)

Nathaniel H. Greenberg is an author at National Cancer Institute specializing in pharmacology, medicine, and medicinal chemistry.

Publications per year

1963–2009

6

Publications

6

PROTOCOLS FOR SCREENING CHEMICAL AGENTS AND NATURAL PRODUCTS AGAINST ANIMAL TUMORS AND OTHER BIOLOGICAL SYSTEMS

Ruth I. Geran, Nathaniel H. Greenberg, Marylea MacDonald et al. · Cancer chemotherapy reports. Part 1 · 1972 · 1.1K citations

, , +8

Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 2. On the role of correlation analysis in decision making in drug modification. Toxicity quantitative structure-activity relationships of 1-(X-phenyl)-3,3-dialkyltriazenes in mice

Corwin Hansch, Gerard J. Hatheway, Frank R. Quinn et al. · Journal of Medicinal Chemistry · 1978 · 31 citations

, , +16

Increased Lifespan of Leukemic Mice Treated with Drugs Related to (–)-Emetine

W. R. Jondorf, B. J. Abbott, Nathaniel H. Greenberg et al. · Chemotherapy · 2009 · 25 citations

, , +5

Association of Increased Dihydrofolate Reductase Levels and Chromosome Alteration in Amethopterin-Resistant Sublines of Leukemia L1210<xref ref-type="fn" rid="FN2">2</xref>

Anthony W. Schrecker, John M. Venditti, Nathaniel H. Greenberg et al. · JNCI Journal of the National Cancer Institute · 1963 · 24 citations

, , +7

Dihydrofolate reductase activity of leukemia L1210 during development of methotrexate resistance

Anthony W. Schrecker, J. A. R. Mead, Nathaniel H. Greenberg et al. · Biochemical Pharmacology · 1971 · 12 citations

, , +9

1–5 of 6